A high-frequency QCM biosensing platform for label-free detection of the SARS-CoV-2 spike receptor-binding domain: an aptasensor and an immunosensor.
Analyst
; 148(4): 719-723, 2023 Feb 13.
Article
in English
| MEDLINE | ID: covidwho-2221893
ABSTRACT
Herein, high-frequency quartz crystal microbalance biosensing platforms were constructed using an aptamer and antibody as bioreceptors for fast and label-free detection of the SARS-CoV-2 RBD.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Biosensing Techniques
/
COVID-19
Type of study:
Diagnostic study
Limits:
Humans
Language:
English
Journal:
Analyst
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS